search
Arma
Trends
- 1Germany Bets Its Economic Future On Military Rearmament●Germany Is Staking Its Economic Future On Military Rearmament
Germany is pursuing large-scale military rearmament and framing it as central to its future economic strategy, with defence spending presented as a driver of industrial capacity and growth. Commentators are debating whether defence investment can revive a stagnant German economy, and what the shift means for Europe's security posture and fiscal priorities.
- 2Trump announces Hamas disarmament deal under Gaza peace plan▼Trump announces Hamas disarmament agreement as part of Gaza peace plan
Donald Trump announced that Hamas has agreed to disarm as part of his Gaza peace plan, a major step in US-led efforts to end the war between Israel and Hamas. The announcement was met with intense global attention, with observers weighing whether disarmament will be implemented and what it means for ceasefire arrangements, hostages, and Gaza's future governance.
- 3North Korea warns UN over Japan's rearmament push▼North Korea warns UN of Japan’s ‘attempts at rearmament'
North Korea has warned the United Nations about what it calls Japan's 'attempts at rearmament', voicing alarm at Japan's expanding defense posture. The statement, reported by Anadolu Agency, reflects Pyongyang's long-standing opposition to Japanese military buildup and adds to regional tensions over security policy in East Asia.
- 4North Korea warns Japan's rearmament 'casting war clouds'▼North Korea warns Japan’s rearmament ‘casting war clouds’
North Korea has issued a warning against Japan's rearmament, saying Tokyo's military build-up is 'casting war clouds' over the region. The statement adds to longstanding tensions between Pyongyang and Tokyo, amid Japan's ongoing expansion of its defence capabilities and broader security concerns in East Asia.
- 5
Analysts are weighing the implications of Russia's reportedly successful test of the Sarmat intercontinental ballistic missile, a heavy weapon capable of carrying multiple nuclear warheads. The test is being read as a signal of Russian strategic capability, with discussion focused on what it means for arms control, deterrence, and Western responses.
- 6Pharmacists improvise treatments amid Gaza medical shortages●Pharmacists improvise medical treatments amid Israel-Gaza conflict
Pharmacists in the Gaza Strip are improvising medical treatments as the Israel-Gaza conflict leaves hospitals and pharmacies short of essential supplies. With deliveries of medicines and equipment disrupted by the fighting, health workers are compounding or substituting drugs and adapting available materials to keep treating the wounded and sick. The report highlights the strain on Gaza's health system, which aid agencies warn is close to collapse amid ongoing hostilities and blocked humanitarian access.
- 7Republicans and Democrats unite against pharmacy benefit managers▼Republicans and Democrats find a unifying target: Pharmacy benefit managers
Bipartisan momentum is building in Washington against pharmacy benefit managers, the middlemen who negotiate drug prices and have been blamed for soaring prescription costs. Lawmakers from both parties are pushing for greater oversight and potential reforms of the industry, a rare area of common ground in a divided Congress.
- 8Pharmacists urge France to bring Covid vaccination forward as cases rise●La recrudescence précoce du covid inquiète le syndicat des pharmaciens, qui appelle le gouvernement à avancer la campagn
France's pharmacists' union is warning about an early resurgence of Covid-19 and is calling on the government to move forward the vaccination campaign scheduled for mid-October. Hospitals are already feeling the strain: emergency room visits are reported to have jumped 67% among adults and 16% among children. The union's appeal puts pressure on health authorities to speed up autumn booster plans as infections climb sooner than expected.
- 9Kobayashi Pharmaceutical weighs buyout worth over ¥500 billion●Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese maker at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer worth more than ¥500 billion. The move would mark a major development for a company whose reputation and finances were badly damaged by the scandal, and market watchers are closely following what a takeover could mean for its future.
- 10EU Council adopts overhaul of pharmaceutical rules▼‘Pharma package’: Council adopts new rules for a fairer and more competitive EU pharmaceutical sector
The Council of the European Union has adopted the so-called pharma package, a major revision of the bloc's pharmaceutical legislation aimed at making the sector fairer and more competitive. The reform is intended to modernise rules on medicines' authorisation, availability and affordability across EU member states, and now forms part of the Union's wider health policy agenda.
- 11Europe's rearmament reshapes BAE Systems from the factory floor up▼Europe’s rearmament is reshaping BAE Systems from the factory floor up
Europe's push to rearm is transforming BAE Systems' operations at every level, from production lines to workforce planning, as the UK defence giant scales output to meet surging demand for weapons and equipment. The renewed focus on defence spending across the continent is driving the company to expand manufacturing capacity and reorganise how it builds military hardware.
- 12South Korea becomes ground zero for EV price war▼South Korea becomes ground zero for EV price war as global carmakers slash tags
Global carmakers are cutting electric vehicle prices in South Korea, turning the country into a frontline of an intensifying EV price war, according to KED Global. Aggressive discounting by international manufacturers is putting pressure on local prices and reshaping the competitive landscape in one of the world's most advanced EV markets.
- 13GM warns on US market as carmakers dodge Chinese rivals▼General Motors warns on US market as carmakers seek ‘safe haven’ from Chinese rivals
General Motors has issued a warning about the US car market, according to the Financial Times, as global carmakers increasingly look to the US as a 'safe haven' from intensifying competition with Chinese manufacturers. The comments highlight mounting pressure on legacy automakers from cheap, fast-growing Chinese exports and the prospect of a price war spreading to American soil.
- 14AstraZeneca invests $2bn in cancer drug partnership with Summit Therapeutics●📈 Astrazeneca invests $2bn in cancer drug tie-up Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeu
AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.
- 15Iran's Gharibabadi: Nuclear Disarmament Cannot Spare Israel▼Gharibabadi: Nuclear Disarmament Cannot Be Achieved by Granting Israel Immunity
Iranian diplomat Kazem Gharibabadi said nuclear disarmament cannot be achieved while Israel is granted immunity, arguing that a state widely believed to possess undeclared nuclear weapons cannot be exempted from non-proliferation obligations. His remarks align with Tehran's long-standing criticism of the global non-proliferation regime, which it says applies double standards in the Middle East.
- 16China to build robot, car and pharmaceutical plants in Kazakhstan▼China to launch robot, car and pharmaceutical plants in Kazakhstan
China plans to open new manufacturing facilities in Kazakhstan, including plants producing robots, cars and pharmaceuticals. The projects deepen economic and industrial cooperation between the two neighbours and fit Kazakhstan's push to attract foreign investment and diversify its economy beyond raw materials. The announcement is drawing attention across regional media as a sign of expanding Chinese industrial presence in Central Asia.
- 17Milan exhibition charts Armani's evolution a year after founder's death▼Armani's business and creative evolution on show in Milan a year after founder's death
A year after Giorgio Armani's death, Milan is showcasing the fashion house's business and creative evolution. The presentation highlights how the brand has developed its identity and operations since the passing of its founder, underlining his lasting influence on Italian fashion and the company's future direction.
- 18Armani open to multiple investors for 15% stake sale▼Armani open to more than one investor for sale of 15% stake, CEO says
Giorgio Armani's chief executive said the Italian fashion house is open to bringing in more than one investor as it considers selling a 15% stake. The comment signals flexibility over the structure of the deal, which is being watched closely across the luxury industry as it could shape the future ownership of one of Italy's best-known fashion brands.
- 19US Inflation and Jobs Data Headline Busy Week for Markets▼What to Expect in Markets This Week: Latest US Inflation, Jobs Data; Micron, CarMax Report
Investors are watching a packed week of US economic releases, with the latest inflation and jobs reports set to shape expectations for interest rates. Corporate earnings are also in focus, with memory-chip maker Micron and used-car retailer CarMax due to report results. Traders will look to the data for signals on the economy's direction and what it means for Federal Reserve policy.
- 20EU approves first drug for cerebral adrenoleukodystrophy▼European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease
The European Commission has granted marketing authorization for NEZGLYAL (leriglitazone), making it the first pharmacological treatment approved for cerebral adrenoleukodystrophy, a rare and rapidly progressive neurodegenerative disease that primarily affects young boys. Until now, care options for cALD were limited mainly to stem cell transplantation in eligible patients. The approval is being highlighted as a significant milestone for families affected by the rare disease and for rare-disease drug development in Europe.
- 21Rohit Sharma says retirement doubts never cross his mind, eyes 2027 World Cup▼'The thought will never cross my mind': Rohit Sharma opens up on his future, 2027 ODI World Cup and beyond
India cricketer Rohit Sharma has opened up about his long-term future in international cricket, saying the thought of stepping away never crosses his mind as he looks ahead to the 2027 ODI World Cup and beyond. His comments have drawn attention from fans and pundits weighing whether the veteran batter, now in the latter stage of his career, intends to lead India's campaign at the next 50-over tournament.
- 22
Indian opener Abhishek Sharma is reportedly unhappy with Sunrisers Hyderabad and wants to leave the franchise ahead of the IPL 2027 season, according to a News18 report. The news has quickly drawn attention in both India and the United States, with fans debating his future at the club and where he might go next if he moves.
- 23Rohit Sharma opens up on 2023 World Cup heartbreak▼'I want to forget November 19': Rohit Sharma opens up on 2023 World Cup heartbreak, reveals the bond he shares with Virat Kohli
India captain Rohit Sharma has spoken candidly about the pain of losing the 2023 ODI World Cup final to Australia on November 19 in Ahmedabad, saying he wants to forget the date. He also reflected on his close bond with Virat Kohli, describing the mutual respect and friendship the two senior batsmen share after years playing together for India.
- 24EU approves NEZGLYAL, first drug for childhood cerebral ALD▼European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD
The European Commission has granted marketing authorisation for NEZGLYAL, the first pharmacological treatment for childhood cerebral adrenoleukodystrophy (cALD), a rare and severe genetic brain disorder. Until now, treatment options were largely limited to stem cell transplantation and supportive care. The approval offers a new therapy option for patients across the EU and is being noted in rare disease and biotech circles.
- 25Rohit Sharma opens up on Kohli bond and 2027 World Cup plans●'We're different individuals': Rohit Sharma speaks about relationship with Virat Kohli and 2027 ODI World Cup plans
India cricketer Rohit Sharma has spoken about his relationship with teammate Virat Kohli, saying the two are "different individuals", and addressed his plans around the 2027 ODI World Cup. His comments are drawing attention from cricket fans amid ongoing debate over the veteran batsmen's future in one-day internationals and their roles leading into the tournament.
- 26
India women's cricket captain Harmanpreet Kaur has stepped down from the role, according to an announcement from the International Cricket Council. The decision ends her tenure leading the national side, one of the most prominent positions in Indian sport. Reaction has focused on her captaincy record and what the change means for the team's leadership going forward.
- 27
General Salvatore Luongo, a senior Carabinieri officer, told Tg1 news that in the event of responsibility being established in the Garlasco case, the response of the Arma would be one of absolute firmness. His remarks underline the force's stance as the high-profile investigation continues to attract national attention in Italy.
- 28
Rohit Sharma has passed 12,000 runs in one-day internationals, becoming the fastest to the mark and overtaking Sachin Tendulkar and Ricky Ponting in the record books, during India's second ODI against West Indies. He and Shubman Gill put on a rapid century opening stand, and Rohit tops the list of most sixes in ODIs in 2026, with Gill and Virat Kohli also in the top five. Reports have also highlighted his bond with Kohli and Kohli's World Cup ambitions.
- 29Ex-Arsenal coach Carlos Cuesta leaves Parma by mutual agreement▼Ex-Arsenal coach Carlos Cuesta leaves role as Parma boss after ‘mutual decision’
Carlos Cuesta has left his role as Parma head coach after what the club describes as a mutual decision, ending his first senior management job just months into the Serie A season. The Spaniard joined Parma in June 2025 after five years as an assistant coach at Arsenal under Mikel Arteta, making his move to the Italian top flight one of the more closely watched coaching appointments of the summer.
- 30Rohit Sharma slips on bus stairs before second ODI against West Indies▼Is Rohit Sharma injured before IND vs WI 2nd ODI? Viral video shows veteran Indian opener slip on team bus stairs
India opener Rohit Sharma was filmed slipping on the stairs of the team bus ahead of the second ODI against the West Indies, prompting fans to ask whether the veteran batter had picked up an injury before the match. The clip circulated widely, with supporters speculating about his fitness and availability, though no official confirmation of any injury has been issued by the team.
- 31France's DGA places first firm order with drone maker Harmattan AI▼# Drones # antidrones # DGA # commande # HarmattanAI # défense # France # Drones # counterdrones # DGA # order # Harmatt
France's defence procurement agency, the DGA, has placed its first firm order with Harmattan AI, a French unicorn specialising in autonomous drones and counter-drone systems. The move signals growing French investment in drone and anti-drone technology for its armed forces. Commenters in defence circles highlight it as a boost for a homegrown startup in a fast-moving strategic sector.
- 32Russian Drone Strike Destroys Indian-Owned Pharma Unit In Ukraine●Russian Drone Strike Destroys Indian-Owned Pharma Unit In Ukraine, One Dead
A Russian drone strike has destroyed an Indian-owned pharmaceutical facility in Ukraine, killing one person, according to NDTV reporting. The attack damaged the plant entirely, and news of the death of an Indian-connected business's facility is drawing significant attention in India, where viewers are following the fallout for Indian nationals and commercial interests caught in the war.
- 33
Mexican goalkeeper Armando González is being reported as the most expensive player in Greek football, according to TV Azteca, which details the cost of his move. The story is drawing attention in Mexico, where the young Chivas keeper's transfer and price tag are being widely discussed by fans of the national league.
- 34PT accused of spreading fake news about its opponent●O PT continua fazendo o seu jogo sujo. Diz ser vítima das fake news, mas usa essa “arma” para atacar o adversário. Desta
Critics in Brazil are accusing the Workers' Party (PT) of hypocrisy on disinformation, saying the party presents itself as a victim of fake news while using the same tactic to attack opponents. The accusation targets the PT presidential candidate himself, who allegedly shared a false claim. Commenters are calling the conduct irresponsible and shameful, using the hashtag #PTNão to voice opposition ahead of the election.
- 35
Indian opener Abhishek Sharma is reportedly unhappy with Sunrisers Hyderabad and wants to leave the franchise ahead of IPL 2027, according to News18. The report comes as Sharma features for India at the Asian Games 2026, where the team beat Sri Lanka in the T20 semi-final and is set to face Pakistan in the final for gold. Fans are debating whether he could enter the IPL auction.
- 36
India's Asian Games cricket squad, featuring Tilak Varma among the picked players, is drawing criticism from fans and commentators. Many question why senior players like Shreyas Iyer, Jasprit Bumrah and Axar Patel are being discussed for the Games when the ODI World Cup is approaching, with debate over workload and squad priorities dominating the conversation.
- 37Carlos Cuesta leaves Parma by mutual agreement●Ex-Arsenal coach Carlos Cuesta leaves role as Parma boss after 'mutual decision' https://www.nytimes.com/athletic/763567
Carlos Cuesta has left his role as head coach of Parma after a mutual decision with the Serie A club, The Athletic reports. The Spanish coach, formerly part of Mikel Arteta's backroom staff at Arsenal, took charge of Parma but his tenure has now ended shortly into his spell. Fans are discussing the club's early-season form and who will replace him.
- 38Armatrix Plans Commercial Rollout of Snake-Like Robotic Arms▼ET Startup Awards 2026: Armatrix targets 10-12 pilots, commercial deployment of snake-like robotic arms in
Indian robotics startup Armatrix says it is targeting 10-12 pilot projects ahead of the commercial deployment of its snake-like robotic arms, announcing the plan as part of the ET Startup Awards 2026 coverage. The flexible robotic arms are aimed at industrial applications where conventional rigid robots struggle. The announcement highlights growing investor and media interest in India's deep-tech startup sector.
- 39
Swedish pole vault star Armand Duplantis has called off his entire 2027 indoor season, a decision he reportedly kept secret for a year before announcing it. Swedish media, including Expressen and SVT, are covering the reasons behind the move, which points to a shift in how the world record holder plans his training and competition calendar.
- 40DTC bus strike leaves Delhi streets deserted●Delhi में DTC Bus Strike से सड़कें वीरान-जनता परेशान, कहां है Rekha Gupta सरकार? Sharad Sharma Report
A strike by DTC bus employees has left roads across Delhi largely empty, stranding thousands of commuters who depend on the city's public bus network. Reports from the ground describe widespread hardship for daily travellers and growing frustration with the Rekha Gupta-led Delhi government, which critics say has failed to resolve the dispute and restore services.